| |
 |
|
Class Information
Number: 514/338
Name: Drug, bio-affecting and body treating compositions > Designated organic active ingredient containing (doai) > Heterocyclic carbon compounds containing a hetero ring having chalcogen (i.e., o,s,se or te) or nitrogen as the only ring hetero atoms doai > Hetero ring is six-membered consisting of one nitrogen and five carbon atoms > Additional hetero ring containing > The additional hetero ring is one of the cyclos in a polycyclo ring system > Plural hetero atoms in the polycyclo ring system
Description: Subject matter wherein the polycyclo ring system contains at least two ring hetero atoms.
Patents under this class:
| Patent Number |
Title Of Patent |
Date Issued |
| 6420394 |
Topically applied pharmaceutical formulation |
Jul. 16, 2002 |
| 6413990 |
Arylsulphonamide-substituted benzimidazoles having tryptase-inhibiting activity |
Jul. 2, 2002 |
| 6410569 |
Salt form of pantoprazole |
Jun. 25, 2002 |
| 6407130 |
Carboxamide-substituted benzimidazoles having tryptase-inhibiting activity |
Jun. 18, 2002 |
| 6403616 |
Chemical process and pharmaceutical formulation |
Jun. 11, 2002 |
| 6403621 |
Method for protecting plants |
Jun. 11, 2002 |
| 6399606 |
Neuroprotective agents and methods related thereto |
Jun. 4, 2002 |
| 6391888 |
Topical anesthetics useful for treating cancer |
May. 21, 2002 |
| 6384045 |
Tricyclic and tetracyclic pyrones |
May. 7, 2002 |
| 6384058 |
2,4,6-trisubstituted pryridines with estrogenic activity and methods for the solid phase synthesis thereof |
May. 7, 2002 |
| 6384059 |
Crystalline form of omeprazole |
May. 7, 2002 |
| 6384060 |
2,4,6-trisbstituted pyridines with estrogenic activity and methods for the solid phase synthesis thereof |
May. 7, 2002 |
| 6376538 |
Cell adhesion inhibitors |
Apr. 23, 2002 |
| 6372770 |
Benzoxazoles |
Apr. 16, 2002 |
| 6372779 |
Anti-inflammatory compounds |
Apr. 16, 2002 |
| 6369083 |
2-methoxyimino-2 (pyrinyloxymethyl) phenyl acetamides with polyether derivatives on the pyridine ring |
Apr. 9, 2002 |
| 6369085 |
Form of S-omeprazole |
Apr. 9, 2002 |
| 6369086 |
Substituted oxidole derivatives as protein tyrosine and as protein serine/threonine kinase inhibitors |
Apr. 9, 2002 |
| 6369087 |
Alkoxy substituted benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same |
Apr. 9, 2002 |
| 6365184 |
Oral pharmaceutical dosage forms comprising a proton pump inhibitor and a NSAID |
Apr. 2, 2002 |
| 6365584 |
Arylysulphonamide-substituted benzimidazoles having tryptase-inhibiting activity |
Apr. 2, 2002 |
| 6365605 |
Substituted hydrochromenopyrroles |
Apr. 2, 2002 |
| 6362196 |
Method to treat pain utilizing benzimidazole NMDA/NR2B antagonists |
Mar. 26, 2002 |
| 6355653 |
Amino-triazolopyridine derivatives |
Mar. 12, 2002 |
| 6353006 |
Substituted 2-arylimino heterocycles and compositions containing them, for use as progesterone receptor binding agents |
Mar. 5, 2002 |
| 6348032 |
Method of inhibiting neoplastic cells with benzimidazole derivatives |
Feb. 19, 2002 |
| 6342497 |
2"-deoxy hygromycin derivatives |
Jan. 29, 2002 |
| 6340676 |
4-aryl-1-oxa-9-thia-cyclopenta (b) fluorenes |
Jan. 22, 2002 |
| 6340704 |
Cell differentiation inducing amide derivatives, their production and use |
Jan. 22, 2002 |
| 6339097 |
N-phenylamide and N-pyridylamide derivatives, method of preparing them and pharmaceutical compositions containing them |
Jan. 15, 2002 |
| 6335351 |
Hydroxylansoprazole compositions and methods |
Jan. 1, 2002 |
| 6331552 |
Substituted imidazolidine derivatives, their preparation, their use and pharmaceutical preparations including them |
Dec. 18, 2001 |
| 6326377 |
Substituted hydrochromenopyridines |
Dec. 4, 2001 |
| 6326384 |
Dry blend pharmaceutical unit dosage form |
Dec. 4, 2001 |
| 6326385 |
Methods for treating or preventing pain |
Dec. 4, 2001 |
| 6319904 |
Formulation comprising antibacterial substance and antiulcer substance |
Nov. 20, 2001 |
| 6316474 |
2-benzyl and 2-heteroaryl benzimidazole NMDA/NR2B antagonists |
Nov. 13, 2001 |
| 6316482 |
Benzamide derivatives having a vasopressin antagonistic activity |
Nov. 13, 2001 |
| 6316020 |
Pharmaceutical formulations |
Nov. 13, 2001 |
| 6310050 |
Therapeutic use of compounds with .beta.3-agonist activity |
Oct. 30, 2001 |
| 6310079 |
Benzimidazole cyclooxygenase-2 inhibitors |
Oct. 30, 2001 |
| 6303600 |
Substituted azabicyclic compounds |
Oct. 16, 2001 |
| 6303639 |
Propanolamine derivatives substituted by heterocyclic radicals, processes for their preparation, pharmaceuticals comprising these compounds and their use |
Oct. 16, 2001 |
| 6294586 |
Hydroxyomeprazole compositions and methods |
Sep. 25, 2001 |
| 6291486 |
Polycyclic Dihydrothiazoles, their preparation and use as pharmaceuticals |
Sep. 18, 2001 |
| 6280773 |
Optimally stabilized microgranule comprising 5-pyrrolyl-2-pyridylmethylsulfinylbenzimidazole derivative |
Aug. 28, 2001 |
| 6274600 |
Heteroatom substituted benzoyl derivatives that enhance synaptic responses mediated by AMPA receptors |
Aug. 14, 2001 |
| 6271241 |
Cycloalkyl and aryl fused aminoalkyl-imidazole derivatives: modulators and GLP-1 receptors |
Aug. 7, 2001 |
| 6268385 |
Dry blend pharmaceutical formulations |
Jul. 31, 2001 |
| 6262083 |
Genipin derivative having liver protection activity |
Jul. 17, 2001 |
|
|
|
